About BioAtla
BioAtla is a company based in San Diego (United States) founded in 2007. It operates as a HealthTech. BioAtla has raised $162.31 million across 5 funding rounds from investors including HHS, Janus Henderson Investors and Farallon Capital Management. The company has 76 employees as of December 31, 2024. BioAtla offers products and services including Conditionally Active Biologics (CAB). BioAtla operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Diego, United States
- Employees 76 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioatla, Inc.
-
Annual Revenue
$11 M0as on Dec 31, 2024
-
Net Profit
$-69.78 M43.48as on Dec 31, 2024
-
EBITDA
$-73.02 M43.16as on Dec 31, 2024
-
Total Equity Funding
$162.31 M (USD)
in 5 rounds
-
Latest Funding Round
$72.5 M (USD), Series D
Jul 15, 2020
-
Investors
HHS
& 7 more
-
Employee Count
76
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioAtla
BioAtla is a publicly listed company on the NASDAQ with ticker symbol BCAB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioAtla
BioAtla offers a comprehensive portfolio of products and services, including Conditionally Active Biologics (CAB). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapeutics are developed for targeted cancer treatment activation.
Unlock access to complete
Unlock access to complete
Funding Insights of BioAtla
BioAtla has successfully raised a total of $162.31M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $72.5 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $72.5M
-
First Round
First Round
(11 Apr 2014)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series D - BioAtla | Valuation | Soleus Capital , HBM Healthcare Investments | |
| Apr, 2016 | Amount | Grant - BioAtla | Valuation |
investors |
|
| Jan, 2016 | Amount | Series B - BioAtla | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioAtla
BioAtla has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Janus Henderson Investors and Farallon Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is focused on healthcare by Pfizer's investment arm.
|
Founded Year | Domain | Location | |
|
Multiple investment strategies are pursued by this hedge fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioAtla
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioAtla
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioatla Comparisons
Competitors of BioAtla
BioAtla operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioatla
Frequently Asked Questions about BioAtla
When was BioAtla founded?
BioAtla was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Where is BioAtla located?
BioAtla is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is BioAtla a funded company?
BioAtla is a funded company, having raised a total of $162.31M across 5 funding rounds to date. The company's 1st funding round was a Series B of $45M, raised on Apr 11, 2014.
How many employees does BioAtla have?
As of Dec 31, 2024, the latest employee count at BioAtla is 76.
What is the annual revenue of BioAtla?
Annual revenue of BioAtla is $11M as on Dec 31, 2024.
What does BioAtla do?
BioAtla, a San Diego-based biopharmaceutical company, is focused on developing safer and more effective drugs for cancer treatment. Its proprietary Conditionally Active Biologics (CAB) platform is utilized to create antibodies that activate under specific physiological conditions, targeting the unique microenvironment of diseased tissue. Solutions are provided for improved therapeutic outcomes in the oncology sector.
Who are the top competitors of BioAtla?
BioAtla's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does BioAtla offer?
BioAtla offers Conditionally Active Biologics (CAB).
Is BioAtla publicly traded?
Yes, BioAtla is publicly traded on NASDAQ under the ticker symbol BCAB.
Who are BioAtla's investors?
BioAtla has 8 investors. Key investors include HHS, Janus Henderson Investors, Farallon Capital Management, HBM Healthcare Investments, and Soleus Capital.
What is BioAtla's ticker symbol?
The ticker symbol of BioAtla is BCAB on NASDAQ.